Advertisement

Pricing News: Breaking Pricing News, Comments and Articles.

04:44 EDT 24th May 2013 | BioPortfolio

Pricing News RSSTwitter

Read the latest Pricing News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Pricing.

Search or Follow Our Pricing News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Pricing News.
You can also follow our Pricing news stories on Twitter: @PricingBio

Showing "pricing reimbursement" News Articles 1 to 25 of 4,700+

Friday 24th May 2013

Care Communications, Inc. Signs New Agreement with Novation

Health information management company to serve members of national healthcare supply chain contracting company. Chicago (PRWEB) May 24, 2013 Care Communications, Inc., a nationally recognized leader in health information management (HIM), today announced that it has signed a new three-year agreement with Novation, the leading healthcare supply chain expertise and contracting company for the 65,00...

Qualoupe LIMS from Two Fold Software helps contract testing laboratories grow and develop business

Qualoupe LIMS from Two Fold Software includes specific features to fit with the dynamic needs of contract testing laboratories. As well as providing core LIMS functionalities to support day to day laboratory work, Qualoupe software helps labs meet the challenges of providing analytical testing to clients while still growing and supporting their business. By creating a secure, reliable interface be...

Thursday 23rd May 2013

Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021

Elan Corporation, plc (“Elan”) (NYSE: ELN) today announced the pricing of the offering of US$850 million aggregate principal amount of 6.250% Senior Notes due 2021 (the “Notes”) by its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp. The Notes will be issued at par. The offering is expected to close on May 31, 2...

Venaxis Announces Pricing of Offering of Common Stock and Warrants

CASTLE ROCK, Colo., May 23, 2013 /PRNewswire/ -- Venaxis, Inc. (Nasdaq:  APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its rapid, protein biomarker-based appendicitis test, APPY1, today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock and related warrants to purchase 3,500,000 shares of its common...

Biobetters, drugs that have been improved since their initial incarnations, are demonstrating fantastic growth and leaving their originators well behind

The new report* explains how the more advanced drugs are far outstripping their biologic predecessors in terms of sales and pricing, helping companies maintain revenue at a time when patent expiry is rife. Examples presented in the report include Amgen’s biobetter Neulasta, used for the treatment of neutropenia. It was launched in 2002, 11 years after originator product Neupogen, and gre...

HealthEdge to Present “Adapting to a Changing Payer Marketplace: Insight and Advice from the Front Lines” at AHIP’s Institute 2013

Session will examine the results from HealthEdge’s most recent “State of the Payor” industry survey and their implications for payors preparing to participate in the new healthcare economy HealthEdge®, provider of the only integrated financial, administrative and clinical platform for healthcare payors, today announced that Executive Vice...

Elan Corporation, plc’s Board of Directors Unanimously Reject Royalty Pharma’s Revised Tender Offer

Elan Corporation, plc (NYSE: ELN) (Elan) today announced that its Board of Directors, after careful review and consideration and with the assistance of its executive management team as well as outside financial and legal advisors, has determined that privately held investment firm Royalty Pharma's revised offer (“Royalty Pharma Offer") announced on Monda...

Bon Secours Health System Renews Relationship with MedAssets to Build Upon $25 Million in Financial and Revenue Cycle Performance Improvement

Not-for-profit health system’s focus on charge and reimbursement processes drives greater revenue capture, reimbursement and increased compliance MedAssets (NASDAQ: MDAS) today announced that Maryland-based Bon Secours Health System (Bon Secours) has elected to renew its relationship with the company to drive continued financial performance improveme...

Capario Recognized on Healthcare Informatics’ Top 100 for Fourth Consecutive Year

Survey ranks healthcare IT vendors by total revenue earned Capario, Inc., a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced it is being recognized in Healthcare Informatics’ 2013 HCI 100 listing of top healthcare IT vendors for the fourth consecutive

New Survey: Market Access Trends in 2013

By Michelle Vitko, Senior Research Analyst In today’s pharmaceutical market, which is riddled with austerity measures and healthcare reform, securing favorable reimbursement rates is more difficult than ever.  Cutting Edge Information is kicking o...

Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog

SANTA MONICA, Calif., May 23, 2013 /PRNewswire-USNewswire/ -- Anthem Blue Cross patients with HIV/AIDS may "opt-out" of a program that would have required them to obtain their medications by mail order under a settlement announced today by Consumer Watchdog and Whatley Kallas LLC.  The lawsuit, filed in January in San Diego Superior Court, alleged that Blue Cross's mandatory mail order prog...

Arena Buyout More 'Highly Probable' Than MannKind

ByChris_Roberts:I was compelled to compare the buyout prospect of Arena Pharmaceuticals (ARNA) with MannKind Corporation (MNKD) after reading "Pricing A Highly Probable Takeover Of MannKind" by George Rho. Undoubtedly, late stage development and early-stage sales companies are ripe for picking, as the potential acquirer averts the early-stage risks. If chosen wisely, the gains can far outweigh the...

Lightlake Therapeutics’ Binge Eating Disorder Treatment Phase II Trial Results Presented At APA 2013 Annual Meeting

̶ Binge Eating Disorder Added to DSM-5 ̶̶ Lightlake Therapeutics Inc. (OTCBB: LLTP) (the “Company”, “We” or “Lightlake”), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that results of the Company’s Phase II clinical trial of its nasal spray treatment for Binge...

Find Urgent Care Launches New Site Design and Functionality to Provide Advanced Search Options for Users in Need of an Urgent Care Clinic

Find Urgent Care launches its new website to make searching for walk-in clinics easy. Its new features include searching by zip code and types of services offered, this type of functionality ensures the user finds the clinic that fits their needs. (PRWEB) May 23, 2013 FindUrgentCare.com launched updates to its website to include an advanced urgent care search option for patients. The new advanced...

Study Finds 35 to 42 Percent Daily Cost Savings for Hospitals Using Flexi-Seal® Fecal Management System

SKILLMAN, N.J., May 23, 2013 /PRNewswire/ -- A new study of the costs of managing fecal incontinence in intensive care units (ICUs) at two Canadian hospitals has found a 35 to 42 percent decrease in daily material costs with the Flexi-Seal® Fecal Management System (FMS) compared to the traditional use of bed pads, briefs and linens. The study also showed potential additional health and...

Abbott Laboratories: Undervalued Potential

ByFundamental Analyst:A substantial recovery perspective has factored into the perception regarding the pharmaceutical industry, essentially due to a step away from the patent cliff and introduction of newer products by the pharmaceutical companies. As these companies begin to report a sizable earnings growth, Moody's has established its outlook for the industry as stable. It has also been stated...

VegasHotelEscapes.com Announces Special Vegas Packages For Memorial Day Weekend

(PRWEB) May 23, 2013 Vegas Hotel Escapes, the premier Las Vegas travel agency, is pleased to announce all new vacation packages for the upcoming memorial day weekend.. Travelers interested in coming to Las Vegas for this patriotic holiday will be...

Guest blog: Cell therapy approval and reimbursement must pace in synch within the modern scenarios

Cell therapy approval and reimbursement must pace in synch within the modern scenarios. Gil Van Bokkelen, Athersys CEO, and Micheal Werner, Alliance for Regenerative Medicine [...]

Atlanta Plastic Surgeon Gives Interview about Breast Implants on Real Self

Dr. Mark Deutsch of Perimeter Plastic Surgery in Atlanta provided information about breast implant size, type and placement on the community review site. Atlanta, Ga (PRWEB) May 23, 2013 Dr. Deutsch, an Atlanta plastic surgeon and founder of Perimeter Plastic Surgery, is continuing his participation in question and answer sessions on Real Self, an online community providing real patient reviews o...

National Bathroom Safety Products Provider Announces Hydrotherapy Walk in Bathtubs and Handicap Shower Stalls That Come With Fold up Seats

A popular walk in tub supplier, Aging Safely announces they will now offer hydrotherapy walk in bathtubs and handicap shower systems that come with fold up seats that are built directly into the specialty bathing appliance. Phoenix, AZ (PRWEB) May 23, 2013 A top senior bathtubs company, Aging Safely announces fold up seats for walk in tubs and handicap shower stalls. Finding the best walk in bath...

Zane Benefits Publishes New Information on the Employer Mandate

Park City, Utah (PRWEB) May 23, 2013 Today, Zane Benefits, Inc. published a new information on the employer mandate . Zane Benefits, which provides comprehensive and flexible alternatives to traditional employer sponsored health benefits, is the...

PAREXEL International To Present At Jefferies Healthcare Conference

BOSTON, May 23, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Jefferies Healthcare Conference in New York.  James Winschel, Sr. Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 1:30 p.m. ET on Monday, June 3, 2013. A live webcast of t...

Wednesday 22nd May 2013

Flamel Technologies Obtains Rights to Two Molecules of Trigger Lock Product Line

LYON, FRANCE -- (Marketwired) -- 05/23/13 -- Flamel Technologies (NASDAQ: FLML) today announced that it has exercised its right to regain control of two drugs that use its Trigger Lock™ delivery technology that were formerly being developed in partnership with an undisclosed partner. Trigger Lock is Flamel's proprietary abuse resistant technology for long acting opioid analgesics. Trigger Lock p...

Bloomin' Brands Announces Pricing of Secondary Public Offering of Common Stock

TAMPA, Fla., May 23, 2013 (GLOBE NEWSWIRE) -- Bloomin' Brands, Inc. (the "Company") (Nasdaq:BLMN) announced the pricing of a secondary public offering of 19,000,000 shares of the Company's common stock at a price of $21.50 per share. All of the shares are being offered by certain stockholders of the Company. The offering is expected to close on May 29, 2013, subject to the satisfaction of customa...

Looming Pharma Price War Threatens Indian Oncology Market Growth

The introduction of market-based pricing for all 348 NLEM drugs will prompt pharmaceutical companies to dramatically cut prices in an attempt to maximize profits in a newly devalued sector.


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement